ALMKT:EPA
Mauna Kea Technologies SA
€ 0.15
arrow_downward
-0.77%(-0.0012) Siku 1
5 Ago, 17:35:10 GMT +2 · EUR
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.16
Juu
€ 0.16
Chini
€ 0.15
Mtaji wa soko
29.09M
Wastani wa kiasi cha mauzo
elfu 306.40
Kiasi cha mauzo ya hisa
elfu 184.04
Uwiano wa bei ya hisa na mapato kwa kila hisa
1.26
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
59
Fungua
€ 0.16
Juu
€ 0.16
Chini
€ 0.15
Mtaji wa soko
29.09M
Wastani wa kiasi cha mauzo
elfu 306.40
Kiasi cha mauzo ya hisa
elfu 184.04
Uwiano wa bei ya hisa na mapato kwa kila hisa
1.26
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
59
Habari
Kutoka kwenye vyanzo vya wavuti
The Lufkin Daily News
·
saa 1 iliyopita
FILE PHOTO: SK Hynix take centre stage on Nasdaq market debut
marketscreener.com
·
saa 1 iliyopita
S&P 500 index slipped slightly after the Stockholm stock exchange closed on Wednesday
San Juan Daily Star
·
saa 1 iliyopita
US stock market could ride earnings strength to more gains after S&P 500 hits record
Bloomberg.com
·
saa 1 iliyopita
Asian Stocks Set for Declines as AI Rally Cools: Markets Wrap
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi59
Lilianzishwa2000
Makao makuu-
Sekta-
Tovutimaunakeatech.com
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi